An Open-Label, Non-Comparative Study of FK463 for the Treatment of Invasive Aspergillosis
Active, not recruitingPER-002-99-A
FUJISAWA HEALTH CARE INC,
Updated: 2023-09-04
An Open-Label, Non-Comparative Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis
Active, not recruitingPER-002-99-B
FUJISAWA HEALTH CARE INC,
Updated: 2023-09-04